Iris Acquisition Corp (IRAA)

NASDAQ: IRAA · IEX Real-Time Price · USD
10.68
+0.04 (0.38%)
At close: May 1, 2024, 4:00 PM
10.50
-0.18 (-1.69%)
After-hours: May 3, 2024, 4:00 PM EDT
Market Cap 74.60M
Revenue (ttm) n/a
Net Income (ttm) 5.78M
Shares Out 7.19M
EPS (ttm) 0.11
PE Ratio 97.09
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 139
Open 10.61
Previous Close 10.64
Day's Range 10.30 - 10.68
52-Week Range 10.11 - 11.22
Beta 0.03
Analysts n/a
Price Target n/a
Earnings Date Jan 6, 2023

About IRAA

Iris Acquisition Corp does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as Tribe Capital Growth Corp I and changed its name to Iris Acquisition Corp in July 2022. The company was incorporated in 2020 and is based in George Town, Cayman Islands. Iris Acquisition Corp is a subsidiary of Iris Acquisition Holdings LLC. [Read more]

Industry Shell Companies
Sector Financials
IPO Date Mar 5, 2021
Employees 3
Stock Exchange NASDAQ
Ticker Symbol IRAA
Full Company Profile

Financial Performance

Financial Statements

News

Liminatus Pharma LLC and Iris Acquisition Corp to combine to incorporate and accelerate much-needed cancer treatments

NEW YORK & LONDON--(BUSINESS WIRE)--Liminatus Pharma LLC (“Liminatus”), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies and Iris Acquisition Corp (“Ir...

1 year ago - Business Wire